| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aldosterone | 201 | 2024 | 882 | 13.430 |
Why?
|
| Hypertension | 194 | 2024 | 8614 | 6.910 |
Why?
|
| Angiotensin II | 184 | 2023 | 883 | 5.740 |
Why?
|
| Renin | 146 | 2024 | 646 | 5.360 |
Why?
|
| Sodium Chloride, Dietary | 28 | 2024 | 287 | 4.730 |
Why?
|
| Renin-Angiotensin System | 71 | 2019 | 759 | 4.540 |
Why?
|
| Sodium, Dietary | 42 | 2020 | 425 | 3.780 |
Why?
|
| Zona Glomerulosa | 28 | 2021 | 89 | 3.700 |
Why?
|
| Calmodulin-Binding Proteins | 11 | 2021 | 249 | 3.530 |
Why?
|
| Blood Pressure | 128 | 2024 | 8635 | 3.230 |
Why?
|
| Adrenal Glands | 62 | 2020 | 557 | 2.930 |
Why?
|
| Receptors, Mineralocorticoid | 23 | 2024 | 163 | 2.920 |
Why?
|
| Diet, Sodium-Restricted | 61 | 2023 | 291 | 2.440 |
Why?
|
| Angiotensinogen | 19 | 2021 | 163 | 2.260 |
Why?
|
| Sodium | 93 | 2024 | 1625 | 2.010 |
Why?
|
| Spironolactone | 20 | 2024 | 389 | 1.960 |
Why?
|
| Potassium | 81 | 2020 | 1329 | 1.940 |
Why?
|
| Hyperaldosteronism | 18 | 2020 | 243 | 1.700 |
Why?
|
| Caveolin 1 | 12 | 2020 | 262 | 1.610 |
Why?
|
| Histone Demethylases | 6 | 2020 | 322 | 1.530 |
Why?
|
| Nerve Tissue Proteins | 9 | 2021 | 4455 | 1.400 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 44 | 2019 | 1524 | 1.320 |
Why?
|
| Kidney | 56 | 2023 | 7152 | 1.300 |
Why?
|
| Renal Circulation | 36 | 2010 | 332 | 1.270 |
Why?
|
| Hydrocortisone | 55 | 2020 | 1824 | 1.190 |
Why?
|
| Weightlessness Simulation | 6 | 2006 | 40 | 1.120 |
Why?
|
| Endocrine System | 3 | 2019 | 113 | 1.100 |
Why?
|
| Renal Plasma Flow | 6 | 2021 | 30 | 1.090 |
Why?
|
| Insulin Resistance | 24 | 2018 | 3889 | 1.070 |
Why?
|
| Membrane Proteins | 9 | 2021 | 7941 | 1.050 |
Why?
|
| Antihypertensive Agents | 22 | 2013 | 2083 | 0.970 |
Why?
|
| Hypotension, Orthostatic | 7 | 2006 | 255 | 0.930 |
Why?
|
| Estrogen Receptor beta | 2 | 2021 | 175 | 0.890 |
Why?
|
| Thyrotropin | 4 | 2021 | 855 | 0.860 |
Why?
|
| Polymorphism, Single Nucleotide | 27 | 2023 | 15657 | 0.840 |
Why?
|
| Adrenocorticotropic Hormone | 44 | 2006 | 647 | 0.820 |
Why?
|
| Hypertension, Renal | 10 | 2021 | 176 | 0.780 |
Why?
|
| Enalapril | 14 | 2006 | 327 | 0.770 |
Why?
|
| Homeostasis | 23 | 2020 | 3343 | 0.760 |
Why?
|
| Vasoconstrictor Agents | 15 | 2015 | 642 | 0.700 |
Why?
|
| Rats, Wistar | 13 | 2023 | 1906 | 0.690 |
Why?
|
| Cardiovascular System | 7 | 2015 | 834 | 0.680 |
Why?
|
| Thyroid Gland | 3 | 2021 | 1180 | 0.640 |
Why?
|
| Captopril | 25 | 2013 | 272 | 0.630 |
Why?
|
| Adrenal Cortex | 12 | 2005 | 140 | 0.630 |
Why?
|
| Bed Rest | 10 | 2005 | 83 | 0.630 |
Why?
|
| Hemodynamics | 20 | 2021 | 4216 | 0.610 |
Why?
|
| Oxidoreductases, N-Demethylating | 3 | 2012 | 115 | 0.610 |
Why?
|
| Corticosterone | 22 | 2017 | 312 | 0.600 |
Why?
|
| Male | 269 | 2024 | 354311 | 0.600 |
Why?
|
| Myocardium | 9 | 2020 | 4719 | 0.600 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2023 | 3304 | 0.590 |
Why?
|
| Zona Reticularis | 1 | 2017 | 8 | 0.590 |
Why?
|
| Hyperkalemia | 5 | 2016 | 215 | 0.590 |
Why?
|
| Endothelin-1 | 2 | 2017 | 309 | 0.580 |
Why?
|
| Signal Transduction | 19 | 2020 | 23512 | 0.580 |
Why?
|
| Adult | 239 | 2024 | 216658 | 0.550 |
Why?
|
| Hypothyroidism | 2 | 2021 | 670 | 0.550 |
Why?
|
| Vasoconstriction | 11 | 2015 | 596 | 0.550 |
Why?
|
| Genotype | 24 | 2021 | 12970 | 0.540 |
Why?
|
| Mineralocorticoids | 3 | 2012 | 38 | 0.540 |
Why?
|
| Animals | 126 | 2023 | 169600 | 0.530 |
Why?
|
| Humans | 393 | 2024 | 752741 | 0.530 |
Why?
|
| Middle Aged | 199 | 2024 | 216054 | 0.530 |
Why?
|
| Heart | 5 | 2023 | 4458 | 0.520 |
Why?
|
| Sex Characteristics | 6 | 2021 | 2610 | 0.520 |
Why?
|
| Cardiovascular Deconditioning | 2 | 2005 | 9 | 0.510 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2021 | 17635 | 0.500 |
Why?
|
| Female | 249 | 2024 | 385090 | 0.500 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 2191 | 0.500 |
Why?
|
| Calcium Channel Blockers | 8 | 2003 | 695 | 0.480 |
Why?
|
| Sodium Chloride | 19 | 2023 | 630 | 0.470 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2024 | 2101 | 0.470 |
Why?
|
| Rats | 59 | 2023 | 24248 | 0.470 |
Why?
|
| Insulin | 21 | 2017 | 6623 | 0.460 |
Why?
|
| Caveolins | 1 | 2014 | 105 | 0.460 |
Why?
|
| NG-Nitroarginine Methyl Ester | 9 | 2023 | 254 | 0.450 |
Why?
|
| Cardiovascular Diseases | 11 | 2023 | 15433 | 0.440 |
Why?
|
| Vesicovaginal Fistula | 1 | 2012 | 13 | 0.440 |
Why?
|
| Haplotypes | 5 | 2012 | 2776 | 0.440 |
Why?
|
| Iodide Peroxidase | 2 | 2021 | 297 | 0.430 |
Why?
|
| Nitric Oxide Synthase Type III | 6 | 2013 | 695 | 0.420 |
Why?
|
| Angiotensin I | 6 | 2004 | 57 | 0.410 |
Why?
|
| Phenotype | 21 | 2023 | 16484 | 0.410 |
Why?
|
| Adaptation, Physiological | 4 | 2006 | 1303 | 0.400 |
Why?
|
| Pelvic Floor | 1 | 2012 | 141 | 0.390 |
Why?
|
| Calcium | 21 | 2012 | 5774 | 0.390 |
Why?
|
| Albuminuria | 6 | 2019 | 670 | 0.380 |
Why?
|
| Mice, Knockout | 15 | 2020 | 14596 | 0.370 |
Why?
|
| Glucocorticoids | 4 | 2012 | 2129 | 0.370 |
Why?
|
| Polymorphism, Genetic | 13 | 2017 | 4327 | 0.360 |
Why?
|
| Hypothalamo-Hypophyseal System | 10 | 2021 | 703 | 0.360 |
Why?
|
| Kidney Diseases | 4 | 2019 | 2136 | 0.360 |
Why?
|
| Vasodilation | 9 | 2015 | 946 | 0.360 |
Why?
|
| Head-Down Tilt | 8 | 2006 | 64 | 0.360 |
Why?
|
| Heart Failure | 13 | 2023 | 11096 | 0.350 |
Why?
|
| Joint Diseases | 1 | 2014 | 484 | 0.340 |
Why?
|
| Alleles | 9 | 2021 | 6954 | 0.340 |
Why?
|
| Sex Factors | 14 | 2020 | 10469 | 0.340 |
Why?
|
| Education, Graduate | 1 | 2010 | 81 | 0.340 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2013 | 1495 | 0.330 |
Why?
|
| Posture | 25 | 2005 | 962 | 0.330 |
Why?
|
| Polymers | 1 | 2016 | 1625 | 0.330 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 5 | 2008 | 281 | 0.320 |
Why?
|
| Amlodipine | 4 | 2021 | 82 | 0.320 |
Why?
|
| Heart Diseases | 3 | 2019 | 2802 | 0.310 |
Why?
|
| Receptors, Angiotensin | 7 | 2001 | 142 | 0.310 |
Why?
|
| RNA, Messenger | 11 | 2023 | 13011 | 0.310 |
Why?
|
| PPAR gamma | 2 | 2010 | 491 | 0.310 |
Why?
|
| Diltiazem | 5 | 1998 | 131 | 0.310 |
Why?
|
| Musculoskeletal Diseases | 1 | 2014 | 590 | 0.300 |
Why?
|
| Receptor, Angiotensin, Type 1 | 5 | 2011 | 152 | 0.290 |
Why?
|
| Cardiomegaly | 1 | 2010 | 607 | 0.290 |
Why?
|
| Gene Expression Regulation | 6 | 2014 | 12054 | 0.290 |
Why?
|
| Nucleotides | 3 | 2024 | 473 | 0.290 |
Why?
|
| Weightlessness | 2 | 2005 | 91 | 0.290 |
Why?
|
| Cushing Syndrome | 8 | 2020 | 248 | 0.290 |
Why?
|
| Blood Glucose | 21 | 2018 | 6318 | 0.280 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3480 | 0.280 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2010 | 204 | 0.280 |
Why?
|
| Immobilization | 2 | 2006 | 234 | 0.280 |
Why?
|
| Postural Orthostatic Tachycardia Syndrome | 3 | 2012 | 53 | 0.280 |
Why?
|
| Teprotide | 16 | 1985 | 28 | 0.280 |
Why?
|
| Interleukin-6 | 3 | 2023 | 3198 | 0.270 |
Why?
|
| Rats, Inbred Strains | 17 | 1992 | 2182 | 0.270 |
Why?
|
| Hydroxysteroid Dehydrogenases | 2 | 1998 | 29 | 0.260 |
Why?
|
| Mice | 27 | 2021 | 81766 | 0.260 |
Why?
|
| Body Mass Index | 15 | 2012 | 12821 | 0.260 |
Why?
|
| Aerospace Medicine | 1 | 2006 | 91 | 0.260 |
Why?
|
| Environment | 1 | 2011 | 1123 | 0.260 |
Why?
|
| Caloric Restriction | 2 | 2018 | 301 | 0.250 |
Why?
|
| Aged | 75 | 2024 | 165629 | 0.250 |
Why?
|
| Renal Artery | 5 | 2000 | 390 | 0.250 |
Why?
|
| Radioimmunoassay | 21 | 2010 | 917 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 35 | 2013 | 10914 | 0.250 |
Why?
|
| Progesterone | 5 | 2010 | 779 | 0.250 |
Why?
|
| Sugar Phosphates | 3 | 1989 | 43 | 0.250 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2005 | 854 | 0.250 |
Why?
|
| Adolescent | 48 | 2024 | 86713 | 0.250 |
Why?
|
| Inositol Phosphates | 3 | 1989 | 179 | 0.240 |
Why?
|
| Young Adult | 17 | 2024 | 57267 | 0.240 |
Why?
|
| Angiotensins | 5 | 1991 | 150 | 0.240 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5064 | 0.240 |
Why?
|
| Pituitary-Adrenal System | 10 | 2012 | 552 | 0.230 |
Why?
|
| Nifedipine | 7 | 2000 | 225 | 0.230 |
Why?
|
| Saralasin | 13 | 1989 | 39 | 0.230 |
Why?
|
| Cytosol | 7 | 1996 | 906 | 0.230 |
Why?
|
| Dopamine | 9 | 1994 | 1584 | 0.230 |
Why?
|
| Stroke | 3 | 2023 | 10152 | 0.230 |
Why?
|
| Metoclopramide | 6 | 1990 | 51 | 0.230 |
Why?
|
| Glucose | 10 | 2016 | 4396 | 0.220 |
Why?
|
| Myocardial Infarction | 4 | 2023 | 11824 | 0.220 |
Why?
|
| Water-Electrolyte Balance | 5 | 2019 | 346 | 0.220 |
Why?
|
| Verapamil | 6 | 2005 | 244 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2012 | 11909 | 0.220 |
Why?
|
| Genetic Variation | 4 | 2011 | 6567 | 0.220 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2017 | 301 | 0.220 |
Why?
|
| Sociology, Medical | 1 | 2003 | 64 | 0.220 |
Why?
|
| Quality of Life | 14 | 2011 | 13044 | 0.210 |
Why?
|
| Catecholamines | 5 | 2010 | 387 | 0.210 |
Why?
|
| Estradiol | 6 | 2010 | 2025 | 0.210 |
Why?
|
| Hydrochlorothiazide | 6 | 2003 | 98 | 0.200 |
Why?
|
| Secretory Pathway | 1 | 2021 | 52 | 0.200 |
Why?
|
| Aorta | 6 | 2015 | 2063 | 0.200 |
Why?
|
| Cholesterol, LDL | 4 | 2020 | 2385 | 0.200 |
Why?
|
| Proline | 9 | 1984 | 461 | 0.190 |
Why?
|
| Aging | 8 | 2017 | 8752 | 0.190 |
Why?
|
| Cells, Cultured | 16 | 2021 | 19270 | 0.190 |
Why?
|
| Potassium Channels | 3 | 1992 | 556 | 0.190 |
Why?
|
| Circadian Rhythm | 8 | 2003 | 2557 | 0.190 |
Why?
|
| Infusions, Intravenous | 12 | 2012 | 2289 | 0.190 |
Why?
|
| Propranolol | 6 | 2011 | 501 | 0.190 |
Why?
|
| 17-Hydroxycorticosteroids | 17 | 1990 | 40 | 0.190 |
Why?
|
| Melatonin | 2 | 2003 | 661 | 0.190 |
Why?
|
| Receptors, Cell Surface | 7 | 2011 | 2881 | 0.190 |
Why?
|
| Thyroid Function Tests | 1 | 2021 | 292 | 0.180 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 3 | 2016 | 452 | 0.180 |
Why?
|
| Adrenal Medulla | 3 | 1989 | 58 | 0.180 |
Why?
|
| Gene Frequency | 7 | 2016 | 3591 | 0.180 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 2010 | 1586 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5858 | 0.180 |
Why?
|
| Renal Veins | 1 | 2000 | 107 | 0.180 |
Why?
|
| Diet | 25 | 2020 | 7969 | 0.180 |
Why?
|
| Linkage Disequilibrium | 4 | 2012 | 1999 | 0.170 |
Why?
|
| Aminopeptidases | 1 | 2019 | 88 | 0.170 |
Why?
|
| Hormones | 6 | 2014 | 896 | 0.170 |
Why?
|
| Risk Factors | 24 | 2023 | 73094 | 0.170 |
Why?
|
| Natriuresis | 13 | 2003 | 124 | 0.170 |
Why?
|
| Biphenyl Compounds | 5 | 2008 | 940 | 0.170 |
Why?
|
| Oligopeptides | 8 | 1985 | 1211 | 0.170 |
Why?
|
| Adiponectin | 4 | 2017 | 1108 | 0.170 |
Why?
|
| Norepinephrine | 9 | 2010 | 912 | 0.170 |
Why?
|
| Postmenopause | 4 | 2008 | 2478 | 0.170 |
Why?
|
| Cohort Studies | 10 | 2021 | 40939 | 0.160 |
Why?
|
| Isradipine | 1 | 1998 | 14 | 0.160 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2019 | 298 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4929 | 0.160 |
Why?
|
| Atenolol | 3 | 2003 | 100 | 0.160 |
Why?
|
| Carrier Proteins | 7 | 2024 | 5006 | 0.160 |
Why?
|
| Regional Blood Flow | 9 | 2017 | 1526 | 0.160 |
Why?
|
| Double-Blind Method | 17 | 2020 | 12202 | 0.160 |
Why?
|
| Veins | 3 | 2011 | 771 | 0.160 |
Why?
|
| Tetrazoles | 5 | 2008 | 861 | 0.160 |
Why?
|
| Glycyrrhetinic Acid | 1 | 1998 | 18 | 0.160 |
Why?
|
| Estrogens | 7 | 2014 | 1573 | 0.160 |
Why?
|
| Kinetics | 21 | 1993 | 6482 | 0.150 |
Why?
|
| Vasodilator Agents | 9 | 2011 | 974 | 0.150 |
Why?
|
| Phosphatidylinositols | 2 | 1989 | 292 | 0.150 |
Why?
|
| Sulfones | 1 | 2020 | 436 | 0.150 |
Why?
|
| Ion Transport | 1 | 2018 | 319 | 0.150 |
Why?
|
| Age Factors | 15 | 2019 | 18460 | 0.150 |
Why?
|
| Sleep Deprivation | 1 | 2004 | 815 | 0.150 |
Why?
|
| Resistin | 3 | 2016 | 170 | 0.150 |
Why?
|
| Prostaglandins | 6 | 1984 | 406 | 0.150 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 2322 | 0.150 |
Why?
|
| Cyclic GMP | 3 | 2015 | 407 | 0.150 |
Why?
|
| Fasting | 4 | 2011 | 1607 | 0.150 |
Why?
|
| Reference Values | 15 | 2010 | 4994 | 0.150 |
Why?
|
| Meniere Disease | 1 | 2018 | 162 | 0.150 |
Why?
|
| p-Aminohippuric Acid | 10 | 2014 | 36 | 0.150 |
Why?
|
| Sympathetic Nervous System | 5 | 2010 | 513 | 0.140 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 1993 | 512 | 0.140 |
Why?
|
| Enzyme Inhibitors | 8 | 2015 | 3766 | 0.140 |
Why?
|
| Baroreflex | 2 | 2012 | 146 | 0.140 |
Why?
|
| Desoxycorticosterone | 7 | 1979 | 50 | 0.140 |
Why?
|
| Sirolimus | 1 | 2024 | 1568 | 0.140 |
Why?
|
| Hypoventilation | 1 | 2016 | 38 | 0.140 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 25454 | 0.140 |
Why?
|
| Time Factors | 36 | 2020 | 40195 | 0.140 |
Why?
|
| Antiporters | 3 | 1999 | 279 | 0.140 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 1883 | 0.140 |
Why?
|
| Kallikreins | 5 | 2010 | 258 | 0.140 |
Why?
|
| Dipeptides | 6 | 1994 | 413 | 0.130 |
Why?
|
| Nitric Oxide | 3 | 2015 | 2152 | 0.130 |
Why?
|
| Vascular Resistance | 5 | 2005 | 950 | 0.130 |
Why?
|
| Sleep Apnea, Central | 1 | 2016 | 84 | 0.130 |
Why?
|
| Genetic Association Studies | 4 | 2017 | 2711 | 0.130 |
Why?
|
| Dyslipidemias | 2 | 2020 | 865 | 0.130 |
Why?
|
| Parathyroid Hormone | 3 | 2013 | 1812 | 0.130 |
Why?
|
| Hyperlipidemias | 1 | 2020 | 797 | 0.130 |
Why?
|
| Leg | 3 | 2005 | 1123 | 0.130 |
Why?
|
| Pressoreceptors | 2 | 1994 | 101 | 0.130 |
Why?
|
| Psychological Tests | 2 | 1997 | 649 | 0.120 |
Why?
|
| 18-Hydroxydesoxycorticosterone | 3 | 1979 | 3 | 0.120 |
Why?
|
| Prostaglandins E | 5 | 1984 | 172 | 0.120 |
Why?
|
| Endorphins | 2 | 1985 | 75 | 0.120 |
Why?
|
| Ear, Inner | 1 | 2018 | 423 | 0.120 |
Why?
|
| Erythrocytes | 5 | 1999 | 2463 | 0.120 |
Why?
|
| Midodrine | 2 | 2006 | 22 | 0.120 |
Why?
|
| Fludrocortisone | 2 | 2012 | 24 | 0.120 |
Why?
|
| Diabetes Mellitus | 5 | 2016 | 5799 | 0.120 |
Why?
|
| Arginine Vasopressin | 2 | 1991 | 130 | 0.120 |
Why?
|
| Potassium, Dietary | 2 | 2012 | 96 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 2011 | 1235 | 0.120 |
Why?
|
| Digoxin | 5 | 1994 | 249 | 0.120 |
Why?
|
| Steroid Hydroxylases | 1 | 1993 | 96 | 0.120 |
Why?
|
| Pyrroles | 1 | 2020 | 1145 | 0.110 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2008 | 1217 | 0.110 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2010 | 39 | 0.110 |
Why?
|
| Genome-Wide Association Study | 9 | 2012 | 12432 | 0.110 |
Why?
|
| Patient Compliance | 4 | 2005 | 2708 | 0.110 |
Why?
|
| Ouabain | 3 | 1998 | 264 | 0.110 |
Why?
|
| Disease Models, Animal | 9 | 2018 | 18174 | 0.110 |
Why?
|
| Saponins | 4 | 1994 | 51 | 0.110 |
Why?
|
| Gene Expression | 4 | 2021 | 7771 | 0.110 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 5 | 1998 | 495 | 0.110 |
Why?
|
| Hypoaldosteronism | 1 | 1992 | 8 | 0.110 |
Why?
|
| Diabetic Nephropathies | 4 | 2006 | 976 | 0.110 |
Why?
|
| Muscle Relaxation | 2 | 2010 | 142 | 0.110 |
Why?
|
| Eclampsia | 1 | 1993 | 59 | 0.110 |
Why?
|
| Hyperuricemia | 2 | 2006 | 210 | 0.110 |
Why?
|
| Clinical Trials as Topic | 9 | 2021 | 7970 | 0.110 |
Why?
|
| Adipokines | 2 | 2012 | 324 | 0.110 |
Why?
|
| Genetic Markers | 2 | 2011 | 2633 | 0.110 |
Why?
|
| Family Health | 3 | 2003 | 1279 | 0.110 |
Why?
|
| Blood Volume | 6 | 2004 | 564 | 0.110 |
Why?
|
| Depression, Postpartum | 1 | 1997 | 345 | 0.100 |
Why?
|
| Bradykinin | 11 | 1983 | 214 | 0.100 |
Why?
|
| Kidney Glomerulus | 2 | 2003 | 697 | 0.100 |
Why?
|
| Periodicity | 3 | 2004 | 362 | 0.100 |
Why?
|
| Peptidyl-Dipeptidase A | 3 | 2006 | 365 | 0.100 |
Why?
|
| Genetic Loci | 3 | 2010 | 2614 | 0.100 |
Why?
|
| Endocrine System Diseases | 1 | 1994 | 256 | 0.100 |
Why?
|
| Fumarates | 1 | 2012 | 133 | 0.100 |
Why?
|
| Cattle | 9 | 1995 | 3926 | 0.100 |
Why?
|
| Edema | 2 | 2010 | 800 | 0.100 |
Why?
|
| Feedback | 6 | 2001 | 792 | 0.100 |
Why?
|
| Cyclic AMP | 2 | 1986 | 1480 | 0.100 |
Why?
|
| Endocrine Glands | 3 | 2004 | 103 | 0.100 |
Why?
|
| Hydroxycholecalciferols | 1 | 2011 | 44 | 0.100 |
Why?
|
| Triglycerides | 6 | 2016 | 2465 | 0.100 |
Why?
|
| Adrenergic Fibers | 1 | 2010 | 21 | 0.100 |
Why?
|
| Obesity | 7 | 2012 | 12868 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2014 | 5149 | 0.100 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1993 | 421 | 0.100 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2012 | 191 | 0.100 |
Why?
|
| Drug Therapy, Combination | 7 | 2008 | 6493 | 0.100 |
Why?
|
| Cortodoxone | 2 | 1990 | 13 | 0.100 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 9431 | 0.090 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2011 | 544 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2008 | 1119 | 0.090 |
Why?
|
| Adrenal Gland Neoplasms | 8 | 1980 | 742 | 0.090 |
Why?
|
| Case-Control Studies | 10 | 2012 | 21904 | 0.090 |
Why?
|
| Methyldopa | 2 | 1987 | 20 | 0.090 |
Why?
|
| Enzyme Precursors | 3 | 2001 | 174 | 0.090 |
Why?
|
| Predictive Value of Tests | 7 | 2012 | 15164 | 0.090 |
Why?
|
| Calcifediol | 1 | 2011 | 165 | 0.090 |
Why?
|
| Kinins | 5 | 2004 | 22 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2019 | 8414 | 0.090 |
Why?
|
| Uric Acid | 2 | 2006 | 776 | 0.090 |
Why?
|
| Amides | 1 | 2012 | 461 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 22009 | 0.090 |
Why?
|
| Random Allocation | 5 | 2021 | 2426 | 0.090 |
Why?
|
| Health Status | 1 | 2003 | 4077 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 10 | 2014 | 2160 | 0.080 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 12250 | 0.080 |
Why?
|
| Adrenal Gland Diseases | 2 | 1980 | 138 | 0.080 |
Why?
|
| Creatinine | 13 | 2008 | 1893 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1270 | 0.080 |
Why?
|
| Glucose Clamp Technique | 3 | 2001 | 267 | 0.080 |
Why?
|
| Depressive Disorder, Major | 4 | 2012 | 4692 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2016 | 2987 | 0.080 |
Why?
|
| Receptors, Calcitriol | 1 | 2011 | 348 | 0.080 |
Why?
|
| Tryptophan | 1 | 2010 | 477 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 5 | 2012 | 1364 | 0.080 |
Why?
|
| Heart Rate | 8 | 2011 | 4108 | 0.080 |
Why?
|
| Epoprostenol | 3 | 1986 | 253 | 0.080 |
Why?
|
| Receptors, Estrogen | 2 | 2014 | 2193 | 0.080 |
Why?
|
| Thrombosis | 2 | 2021 | 3035 | 0.080 |
Why?
|
| Epigenomics | 1 | 2014 | 905 | 0.080 |
Why?
|
| Hypertriglyceridemia | 3 | 2016 | 301 | 0.080 |
Why?
|
| Calcium Channels | 1 | 1992 | 621 | 0.080 |
Why?
|
| Platelet Aggregation | 2 | 1988 | 798 | 0.080 |
Why?
|
| Models, Animal | 4 | 2011 | 2175 | 0.080 |
Why?
|
| Analysis of Variance | 9 | 2006 | 6352 | 0.080 |
Why?
|
| Imidazoles | 1 | 1994 | 1201 | 0.080 |
Why?
|
| Drug Synergism | 6 | 2003 | 1768 | 0.080 |
Why?
|
| Lipids | 2 | 1996 | 3326 | 0.070 |
Why?
|
| Cholesterol | 5 | 2020 | 2926 | 0.070 |
Why?
|
| Plethysmography | 2 | 2005 | 180 | 0.070 |
Why?
|
| Genetics, Medical | 1 | 2010 | 341 | 0.070 |
Why?
|
| Natriuretic Agents | 1 | 1987 | 25 | 0.070 |
Why?
|
| Drug Tolerance | 5 | 2004 | 377 | 0.070 |
Why?
|
| Arginine | 2 | 2010 | 939 | 0.070 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 1999 | 366 | 0.070 |
Why?
|
| Addison Disease | 3 | 1984 | 49 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 1 | 2010 | 914 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 679 | 0.070 |
Why?
|
| Prevalence | 2 | 2020 | 15404 | 0.070 |
Why?
|
| Vasomotor System | 2 | 2004 | 210 | 0.070 |
Why?
|
| Menstrual Cycle | 1 | 2010 | 562 | 0.070 |
Why?
|
| Body Weight | 11 | 2008 | 4703 | 0.070 |
Why?
|
| Linear Models | 6 | 2017 | 5965 | 0.070 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 3686 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 3 | 1999 | 1867 | 0.070 |
Why?
|
| Exons | 1 | 2012 | 2443 | 0.070 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 2 | 1983 | 82 | 0.070 |
Why?
|
| Pregnenolone | 3 | 1996 | 26 | 0.070 |
Why?
|
| Arteries | 1 | 2011 | 1123 | 0.070 |
Why?
|
| C-Reactive Protein | 3 | 2023 | 3814 | 0.070 |
Why?
|
| Serum Albumin | 1 | 2009 | 680 | 0.070 |
Why?
|
| Infusions, Parenteral | 10 | 1997 | 419 | 0.070 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 2 | 1998 | 6 | 0.070 |
Why?
|
| Hyponatremia | 4 | 1984 | 286 | 0.070 |
Why?
|
| Hyperglycemia | 2 | 2013 | 1380 | 0.070 |
Why?
|
| Cholesterol, HDL | 3 | 2012 | 1817 | 0.070 |
Why?
|
| Stimulation, Chemical | 9 | 2010 | 325 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2006 | 3374 | 0.070 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 2003 | 76 | 0.060 |
Why?
|
| Syncope | 2 | 2005 | 435 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2000 | 8285 | 0.060 |
Why?
|
| Chronobiology Disorders | 1 | 2006 | 72 | 0.060 |
Why?
|
| Fura-2 | 3 | 1990 | 108 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6169 | 0.060 |
Why?
|
| Specialization | 1 | 2010 | 777 | 0.060 |
Why?
|
| Blood Proteins | 4 | 1994 | 1145 | 0.060 |
Why?
|
| Forearm | 1 | 2007 | 419 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2005 | 287 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 477 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 18050 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 7 | 1992 | 378 | 0.060 |
Why?
|
| Acromegaly | 3 | 1980 | 348 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 485 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2009 | 1255 | 0.060 |
Why?
|
| Benzofurans | 3 | 1990 | 139 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2011 | 917 | 0.060 |
Why?
|
| Glucose Tolerance Test | 3 | 2012 | 1168 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2020 | 10057 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2005 | 414 | 0.060 |
Why?
|
| F2-Isoprostanes | 1 | 2003 | 35 | 0.060 |
Why?
|
| Potassium Chloride | 4 | 1997 | 238 | 0.060 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 1983 | 49 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 1999 | 4316 | 0.060 |
Why?
|
| Quantitative Trait Loci | 3 | 2010 | 2049 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 2087 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 1993 | 1236 | 0.060 |
Why?
|
| Career Choice | 1 | 2010 | 751 | 0.060 |
Why?
|
| History, 16th Century | 1 | 2003 | 72 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2004 | 135 | 0.060 |
Why?
|
| Program Development | 1 | 2010 | 1314 | 0.060 |
Why?
|
| Apolipoproteins C | 1 | 2003 | 60 | 0.060 |
Why?
|
| Cholesterol, VLDL | 1 | 2003 | 65 | 0.060 |
Why?
|
| Rats, Inbred WKY | 3 | 1993 | 158 | 0.060 |
Why?
|
| Supine Position | 2 | 2001 | 205 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2011 | 4194 | 0.050 |
Why?
|
| Growth Hormone | 6 | 1993 | 706 | 0.050 |
Why?
|
| Tetraethylammonium Compounds | 2 | 1992 | 32 | 0.050 |
Why?
|
| Calmodulin | 1 | 1983 | 206 | 0.050 |
Why?
|
| Tetraethylammonium | 2 | 1992 | 58 | 0.050 |
Why?
|
| Amniotic Fluid | 1 | 1984 | 373 | 0.050 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2004 | 276 | 0.050 |
Why?
|
| Blood Platelets | 2 | 1984 | 2526 | 0.050 |
Why?
|
| Phenylephrine | 2 | 2015 | 301 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 4 | 1994 | 2499 | 0.050 |
Why?
|
| Indomethacin | 4 | 1984 | 331 | 0.050 |
Why?
|
| Calcium Channels, L-Type | 1 | 2023 | 240 | 0.050 |
Why?
|
| Magnesium | 3 | 1992 | 813 | 0.050 |
Why?
|
| 17-Ketosteroids | 12 | 1977 | 39 | 0.050 |
Why?
|
| Inflammation | 3 | 2012 | 10751 | 0.050 |
Why?
|
| Guanylate Cyclase | 2 | 2013 | 201 | 0.050 |
Why?
|
| Space Simulation | 1 | 2001 | 9 | 0.050 |
Why?
|
| Motor Activity | 1 | 2012 | 2715 | 0.050 |
Why?
|
| Skin Diseases | 1 | 2010 | 1073 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2004 | 1779 | 0.050 |
Why?
|
| Immunoradiometric Assay | 1 | 2001 | 24 | 0.050 |
Why?
|
| Membrane Potentials | 3 | 1992 | 1129 | 0.050 |
Why?
|
| Thyroxine | 3 | 2004 | 672 | 0.050 |
Why?
|
| Medicine | 1 | 2010 | 950 | 0.050 |
Why?
|
| Epistasis, Genetic | 1 | 2003 | 364 | 0.050 |
Why?
|
| Pravastatin | 1 | 2023 | 395 | 0.050 |
Why?
|
| Electrophysiology | 3 | 1992 | 1299 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2006 | 2978 | 0.050 |
Why?
|
| Chlorides | 3 | 1981 | 667 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2003 | 722 | 0.050 |
Why?
|
| Ovariectomy | 2 | 2008 | 665 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4733 | 0.050 |
Why?
|
| Models, Biological | 5 | 2011 | 9569 | 0.050 |
Why?
|
| Fibrinolysis | 3 | 2001 | 327 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2001 | 177 | 0.050 |
Why?
|
| Endothelial Cells | 2 | 2011 | 3518 | 0.050 |
Why?
|
| Nutritional Status | 2 | 2020 | 1610 | 0.050 |
Why?
|
| Genetic Linkage | 3 | 2005 | 2409 | 0.050 |
Why?
|
| Pheochromocytoma | 3 | 1980 | 333 | 0.050 |
Why?
|
| Benzimidazoles | 3 | 2004 | 855 | 0.050 |
Why?
|
| Cough | 1 | 2004 | 566 | 0.050 |
Why?
|
| Epinephrine | 5 | 2010 | 794 | 0.050 |
Why?
|
| Simvastatin | 1 | 2023 | 362 | 0.050 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 2 | 1993 | 30 | 0.050 |
Why?
|
| Adrenalectomy | 6 | 2000 | 342 | 0.040 |
Why?
|
| Cardiac Output | 2 | 2002 | 850 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1984 | 1469 | 0.040 |
Why?
|
| Epidemiology | 1 | 2003 | 287 | 0.040 |
Why?
|
| Regression Analysis | 6 | 2012 | 6458 | 0.040 |
Why?
|
| Muscle, Smooth | 2 | 1974 | 943 | 0.040 |
Why?
|
| Diuresis | 3 | 1982 | 113 | 0.040 |
Why?
|
| Osmolar Concentration | 5 | 2004 | 679 | 0.040 |
Why?
|
| Peritoneal Dialysis | 2 | 1998 | 148 | 0.040 |
Why?
|
| Sensitivity and Specificity | 5 | 2003 | 14761 | 0.040 |
Why?
|
| Parathyroid Glands | 2 | 2013 | 510 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2003 | 475 | 0.040 |
Why?
|
| Muscle Cramp | 1 | 1999 | 35 | 0.040 |
Why?
|
| Dexamethasone | 7 | 1985 | 1945 | 0.040 |
Why?
|
| Tilt-Table Test | 3 | 2005 | 79 | 0.040 |
Why?
|
| Homovanillic Acid | 1 | 1999 | 75 | 0.040 |
Why?
|
| Prognosis | 7 | 2020 | 29264 | 0.040 |
Why?
|
| Secretory Rate | 6 | 1976 | 82 | 0.040 |
Why?
|
| Rabbits | 6 | 2011 | 4910 | 0.040 |
Why?
|
| Receptors, Drug | 2 | 1976 | 162 | 0.040 |
Why?
|
| Polyuria | 1 | 1999 | 39 | 0.040 |
Why?
|
| Tritium | 8 | 1974 | 745 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2004 | 979 | 0.040 |
Why?
|
| Adrenal Insufficiency | 3 | 1978 | 185 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2012 | 6037 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2002 | 2559 | 0.040 |
Why?
|
| Administration, Intravaginal | 1 | 1999 | 154 | 0.040 |
Why?
|
| Fibrin | 1 | 2021 | 508 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 1989 | 114 | 0.040 |
Why?
|
| Antibody Specificity | 3 | 2000 | 1089 | 0.040 |
Why?
|
| Endolymphatic Hydrops | 1 | 2018 | 30 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2002 | 893 | 0.040 |
Why?
|
| Ammonia | 2 | 1976 | 236 | 0.040 |
Why?
|
| Pituitary Gland | 3 | 1978 | 667 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 1988 | 2457 | 0.040 |
Why?
|
| Sella Turcica | 2 | 1978 | 120 | 0.040 |
Why?
|
| Treatment Outcome | 9 | 2012 | 64017 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 1995 | 1223 | 0.040 |
Why?
|
| Diuretics | 4 | 2013 | 596 | 0.040 |
Why?
|
| Dialysis Solutions | 1 | 1998 | 34 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 1983 | 1071 | 0.040 |
Why?
|
| Mibefradil | 1 | 1998 | 6 | 0.040 |
Why?
|
| Tetrahydroisoquinolines | 1 | 1998 | 90 | 0.040 |
Why?
|
| Endolymphatic Sac | 1 | 2018 | 50 | 0.040 |
Why?
|
| DNA | 1 | 2012 | 7312 | 0.040 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 39223 | 0.040 |
Why?
|
| Dihydropyridines | 1 | 1998 | 67 | 0.040 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 58 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2006 | 2332 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13778 | 0.040 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1977 | 66 | 0.040 |
Why?
|
| Thirst | 1 | 1997 | 38 | 0.040 |
Why?
|
| ACTH Syndrome, Ectopic | 2 | 1992 | 30 | 0.040 |
Why?
|
| Delayed-Action Preparations | 3 | 2003 | 983 | 0.040 |
Why?
|
| Tetrahydronaphthalenes | 1 | 1998 | 89 | 0.040 |
Why?
|
| Adipose Tissue | 4 | 2016 | 3308 | 0.040 |
Why?
|
| Electrolytes | 4 | 1989 | 283 | 0.040 |
Why?
|
| Mutation | 5 | 2020 | 29981 | 0.040 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 82 | 0.040 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 1999 | 249 | 0.040 |
Why?
|
| Hematocrit | 5 | 1993 | 636 | 0.040 |
Why?
|
| Blood Vessels | 3 | 1982 | 1127 | 0.040 |
Why?
|
| Immune Sera | 2 | 1994 | 642 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 4 | 1983 | 189 | 0.040 |
Why?
|
| Binding, Competitive | 3 | 1988 | 1156 | 0.040 |
Why?
|
| Penile Erection | 1 | 1997 | 97 | 0.040 |
Why?
|
| Gynecomastia | 1 | 1977 | 87 | 0.040 |
Why?
|
| Isoquinolines | 1 | 1998 | 364 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 1999 | 712 | 0.040 |
Why?
|
| Endocrinology | 1 | 2003 | 443 | 0.040 |
Why?
|
| Aldehyde Reductase | 1 | 2016 | 66 | 0.040 |
Why?
|
| Syndrome | 3 | 1997 | 3261 | 0.040 |
Why?
|
| Students, Medical | 1 | 2010 | 1887 | 0.040 |
Why?
|
| United States | 6 | 2023 | 70772 | 0.040 |
Why?
|
| Depressive Disorder | 2 | 2000 | 3759 | 0.040 |
Why?
|
| Tachycardia | 1 | 1999 | 619 | 0.040 |
Why?
|
| Hypokalemia | 3 | 1992 | 156 | 0.030 |
Why?
|
| Chromatography, Paper | 4 | 1987 | 77 | 0.030 |
Why?
|
| Hypoglycemic Agents | 2 | 2013 | 2975 | 0.030 |
Why?
|
| Electric Conductivity | 2 | 1987 | 412 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 93 | 0.030 |
Why?
|
| Gallic Acid | 2 | 1986 | 24 | 0.030 |
Why?
|
| Base Sequence | 3 | 2002 | 12769 | 0.030 |
Why?
|
| Losartan | 2 | 1997 | 303 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2000 | 984 | 0.030 |
Why?
|
| Penis | 1 | 1997 | 221 | 0.030 |
Why?
|
| Cold Temperature | 1 | 1999 | 773 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 427 | 0.030 |
Why?
|
| Pituitary Neoplasms | 2 | 1982 | 1354 | 0.030 |
Why?
|
| Thiazoles | 1 | 2003 | 1484 | 0.030 |
Why?
|
| Depression, Chemical | 4 | 1979 | 190 | 0.030 |
Why?
|
| Medical Records | 2 | 1999 | 1412 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2005 | 2264 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2016 | 587 | 0.030 |
Why?
|
| Buffers | 3 | 1992 | 148 | 0.030 |
Why?
|
| Digitoxin | 1 | 1994 | 22 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 15657 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2003 | 2766 | 0.030 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 4459 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2023 | 53863 | 0.030 |
Why?
|
| Hypertension, Renovascular | 3 | 1980 | 130 | 0.030 |
Why?
|
| Adrenocortical Hyperfunction | 2 | 1971 | 14 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2003 | 1417 | 0.030 |
Why?
|
| Protein Binding | 4 | 2014 | 9408 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2950 | 0.030 |
Why?
|
| beta-Endorphin | 2 | 1985 | 53 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 2 | 2002 | 2729 | 0.030 |
Why?
|
| Demography | 1 | 1999 | 1661 | 0.030 |
Why?
|
| Constipation | 1 | 1999 | 547 | 0.030 |
Why?
|
| Family | 1 | 2005 | 3175 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 268 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1997 | 737 | 0.030 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 1993 | 20 | 0.030 |
Why?
|
| Furosemide | 4 | 1985 | 167 | 0.030 |
Why?
|
| Temporal Bone | 1 | 2018 | 675 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 1974 | 86 | 0.030 |
Why?
|
| Nuclear Family | 3 | 2001 | 318 | 0.030 |
Why?
|
| Adenoma | 4 | 1978 | 2182 | 0.030 |
Why?
|
| Acidosis | 1 | 1976 | 273 | 0.030 |
Why?
|
| NAD | 1 | 2017 | 596 | 0.030 |
Why?
|
| Logistic Models | 2 | 2005 | 13441 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2014 | 4228 | 0.030 |
Why?
|
| Hemodialysis Solutions | 1 | 1993 | 7 | 0.030 |
Why?
|
| Heart Injuries | 1 | 2015 | 209 | 0.030 |
Why?
|
| Cardenolides | 4 | 1994 | 20 | 0.030 |
Why?
|
| Spectrophotometry | 3 | 1988 | 313 | 0.030 |
Why?
|
| Pregnancy | 10 | 1997 | 29630 | 0.030 |
Why?
|
| Hyperinsulinism | 1 | 1996 | 412 | 0.030 |
Why?
|
| Light | 1 | 1999 | 1332 | 0.030 |
Why?
|
| Prazosin | 3 | 1981 | 96 | 0.030 |
Why?
|
| Dermatoglyphics | 1 | 1972 | 21 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 1722 | 0.030 |
Why?
|
| Body Fluids | 1 | 1994 | 319 | 0.030 |
Why?
|
| Psychotic Disorders | 2 | 2006 | 3102 | 0.030 |
Why?
|
| Multigene Family | 1 | 1996 | 1101 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2010 | 20026 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1995 | 495 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 1996 | 1426 | 0.030 |
Why?
|
| Lymphocytes | 2 | 1996 | 2617 | 0.030 |
Why?
|
| Cesium | 1 | 1992 | 38 | 0.030 |
Why?
|
| Fluorescent Dyes | 3 | 1990 | 1919 | 0.030 |
Why?
|
| Barium | 1 | 1992 | 62 | 0.030 |
Why?
|
| Turner Syndrome | 2 | 1974 | 131 | 0.030 |
Why?
|
| Systole | 2 | 2006 | 960 | 0.030 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 1992 | 98 | 0.030 |
Why?
|
| Nadolol | 1 | 1992 | 30 | 0.030 |
Why?
|
| Xenopus | 1 | 2014 | 714 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 1998 | 813 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2004 | 3845 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1160 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 659 | 0.030 |
Why?
|
| Caveolin 3 | 1 | 2011 | 25 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 1992 | 82 | 0.030 |
Why?
|
| Ion Channels | 2 | 1987 | 1051 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 916 | 0.030 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2011 | 16 | 0.020 |
Why?
|
| Pregnancy in Diabetics | 1 | 1993 | 183 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 159 | 0.020 |
Why?
|
| Metyrapone | 2 | 1990 | 23 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 907 | 0.020 |
Why?
|
| Prolactin | 2 | 1983 | 673 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2003 | 1459 | 0.020 |
Why?
|
| Molecular Biology | 1 | 1995 | 591 | 0.020 |
Why?
|
| Hydrogen | 1 | 1992 | 167 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2000 | 345 | 0.020 |
Why?
|
| Homozygote | 1 | 1996 | 1795 | 0.020 |
Why?
|
| Cycloheximide | 3 | 2000 | 349 | 0.020 |
Why?
|
| Postprandial Period | 1 | 2012 | 302 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 1973 | 424 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1992 | 391 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2012 | 517 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6565 | 0.020 |
Why?
|
| Acetylcholine | 2 | 2010 | 624 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1992 | 1572 | 0.020 |
Why?
|
| Hypopituitarism | 3 | 1972 | 254 | 0.020 |
Why?
|
| Testis | 2 | 1974 | 804 | 0.020 |
Why?
|
| Fetal Death | 1 | 1972 | 449 | 0.020 |
Why?
|
| Cross-Over Studies | 3 | 2004 | 2043 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2644 | 0.020 |
Why?
|
| Adenosine Diphosphate | 2 | 1988 | 424 | 0.020 |
Why?
|
| Dinoprostone | 2 | 1984 | 600 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2006 | 58361 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 606 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 588 | 0.020 |
Why?
|
| Child | 6 | 2017 | 78594 | 0.020 |
Why?
|
| Aorta, Thoracic | 2 | 2011 | 1089 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 2010 | 102 | 0.020 |
Why?
|
| Testosterone | 8 | 1977 | 2457 | 0.020 |
Why?
|
| Abetalipoproteinemia | 1 | 1969 | 16 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2017 | 23554 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2010 | 139 | 0.020 |
Why?
|
| Methods | 4 | 1975 | 1132 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 478 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2010 | 152 | 0.020 |
Why?
|
| Cosyntropin | 3 | 1998 | 33 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2016 | 78758 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 1989 | 195 | 0.020 |
Why?
|
| Antibodies | 3 | 1991 | 2454 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2011 | 3746 | 0.020 |
Why?
|
| Texas | 1 | 2010 | 395 | 0.020 |
Why?
|
| Incretins | 1 | 2010 | 90 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 1994 | 980 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2000 | 3147 | 0.020 |
Why?
|
| Microchemistry | 1 | 1988 | 57 | 0.020 |
Why?
|
| Autoanalysis | 2 | 1987 | 72 | 0.020 |
Why?
|
| Vitamin D | 2 | 2013 | 3259 | 0.020 |
Why?
|
| Platelet Count | 2 | 1988 | 784 | 0.020 |
Why?
|
| Isomerism | 1 | 1988 | 197 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2008 | 118 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2006 | 6050 | 0.020 |
Why?
|
| Ovarian Cysts | 1 | 1969 | 115 | 0.020 |
Why?
|
| Nitroprusside | 2 | 1986 | 274 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2003 | 6083 | 0.020 |
Why?
|
| Pedigree | 1 | 1996 | 4637 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2011 | 533 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1654 | 0.020 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1972 | 382 | 0.020 |
Why?
|
| Life Style | 2 | 2012 | 3861 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 202 | 0.020 |
Why?
|
| Monitoring, Physiologic | 2 | 2000 | 1750 | 0.020 |
Why?
|
| Isometric Contraction | 1 | 2008 | 143 | 0.020 |
Why?
|
| Cholecalciferol | 1 | 2012 | 542 | 0.020 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 1988 | 209 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 780 | 0.020 |
Why?
|
| Incidence | 3 | 2013 | 21146 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 766 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 3 | 1973 | 325 | 0.020 |
Why?
|
| Pituitary-Adrenal Function Tests | 4 | 1974 | 30 | 0.020 |
Why?
|
| Models, Cardiovascular | 2 | 2003 | 993 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2007 | 963 | 0.020 |
Why?
|
| Sodium Channels | 1 | 1989 | 348 | 0.020 |
Why?
|
| Dogs | 4 | 1998 | 3915 | 0.020 |
Why?
|
| Enzyme Activation | 3 | 1995 | 3674 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3837 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 1987 | 166 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 1972 | 546 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2006 | 14219 | 0.020 |
Why?
|
| Lanthanum | 1 | 1986 | 30 | 0.020 |
Why?
|
| Species Specificity | 3 | 1991 | 2483 | 0.020 |
Why?
|
| Dantrolene | 1 | 1986 | 26 | 0.020 |
Why?
|
| Bucladesine | 1 | 1986 | 121 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1984 | 10256 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2004 | 35798 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1991 | 2335 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2492 | 0.020 |
Why?
|
| Cations | 1 | 1987 | 233 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 1969 | 355 | 0.020 |
Why?
|
| Placebos | 1 | 2011 | 1675 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2011 | 952 | 0.020 |
Why?
|
| Ferricyanides | 1 | 1986 | 32 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 1986 | 110 | 0.020 |
Why?
|
| Streptozocin | 1 | 2006 | 196 | 0.020 |
Why?
|
| Hirsutism | 3 | 1977 | 68 | 0.020 |
Why?
|
| Metformin | 1 | 2013 | 863 | 0.020 |
Why?
|
| Solutions | 1 | 1987 | 427 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1995 | 2449 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 1992 | 1018 | 0.020 |
Why?
|
| Hypertrophy | 2 | 2006 | 573 | 0.020 |
Why?
|
| Microelectrodes | 1 | 1987 | 304 | 0.020 |
Why?
|
| South Dakota | 1 | 2005 | 30 | 0.020 |
Why?
|
| Sheep | 3 | 1973 | 1445 | 0.020 |
Why?
|
| Mathematics | 1 | 1987 | 727 | 0.020 |
Why?
|
| Phosphates | 1 | 1989 | 782 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1978 | 0.020 |
Why?
|
| Death, Sudden | 1 | 1987 | 310 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1987 | 590 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 5460 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 1985 | 170 | 0.020 |
Why?
|
| Internationality | 1 | 2010 | 999 | 0.020 |
Why?
|
| Statistical Distributions | 1 | 2004 | 64 | 0.020 |
Why?
|
| Founder Effect | 1 | 2005 | 191 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1861 | 0.020 |
Why?
|
| Biological Transport | 1 | 1989 | 2121 | 0.020 |
Why?
|
| Osteopontin | 1 | 2006 | 301 | 0.020 |
Why?
|
| Public Health | 1 | 1998 | 2634 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 1987 | 418 | 0.020 |
Why?
|
| Fluorescence | 1 | 1987 | 753 | 0.020 |
Why?
|
| Quinazolines | 2 | 1981 | 1355 | 0.020 |
Why?
|
| Chemistry | 1 | 1984 | 353 | 0.010 |
Why?
|
| Diagnosis, Differential | 6 | 2000 | 13042 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1984 | 520 | 0.010 |
Why?
|
| Kininogens | 1 | 1983 | 21 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1985 | 405 | 0.010 |
Why?
|
| Benzazepines | 1 | 1986 | 320 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1991 | 1362 | 0.010 |
Why?
|
| Cardiomyopathies | 2 | 2000 | 1895 | 0.010 |
Why?
|
| Angiotensin III | 1 | 1983 | 1 | 0.010 |
Why?
|
| 1-Sarcosine-8-Isoleucine Angiotensin II | 1 | 1983 | 3 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1983 | 273 | 0.010 |
Why?
|
| Gonadotropins | 4 | 1974 | 241 | 0.010 |
Why?
|
| Administration, Oral | 2 | 1990 | 3941 | 0.010 |
Why?
|
| Space Flight | 1 | 2005 | 193 | 0.010 |
Why?
|
| Parasympathetic Nervous System | 1 | 2003 | 141 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 2003 | 185 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1990 | 2702 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11395 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2010 | 1780 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7400 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 7708 | 0.010 |
Why?
|
| Algorithms | 2 | 2016 | 13984 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1995 | 821 | 0.010 |
Why?
|
| Hyperplasia | 2 | 1978 | 1186 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2002 | 334 | 0.010 |
Why?
|
| Age of Onset | 1 | 2009 | 3290 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1973 | 471 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 4723 | 0.010 |
Why?
|
| Amiloride | 2 | 1993 | 121 | 0.010 |
Why?
|
| Biological Assay | 3 | 1974 | 652 | 0.010 |
Why?
|
| Dextrans | 2 | 1993 | 599 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2021 | 12165 | 0.010 |
Why?
|
| France | 1 | 2003 | 515 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1983 | 596 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1987 | 1756 | 0.010 |
Why?
|
| Electrocardiography | 2 | 2005 | 6458 | 0.010 |
Why?
|
| Apolipoprotein C-III | 1 | 2003 | 209 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1984 | 430 | 0.010 |
Why?
|
| Premedication | 1 | 1982 | 258 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1981 | 155 | 0.010 |
Why?
|
| Enzyme Induction | 2 | 1972 | 472 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1984 | 803 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1983 | 494 | 0.010 |
Why?
|
| Italy | 1 | 2003 | 831 | 0.010 |
Why?
|
| Health Surveys | 1 | 2011 | 4050 | 0.010 |
Why?
|
| Ethanolamines | 1 | 1981 | 159 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2009 | 0.010 |
Why?
|
| Karyotyping | 3 | 1974 | 1229 | 0.010 |
Why?
|
| Liver | 1 | 2016 | 7538 | 0.010 |
Why?
|
| Diastole | 1 | 2003 | 792 | 0.010 |
Why?
|
| Cross Reactions | 2 | 1973 | 842 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1981 | 244 | 0.010 |
Why?
|
| Cell Separation | 2 | 1992 | 1751 | 0.010 |
Why?
|
| Mass Screening | 1 | 2016 | 5282 | 0.010 |
Why?
|
| Radiography | 3 | 1982 | 7047 | 0.010 |
Why?
|
| Menopause | 2 | 2000 | 1641 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 193 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 2423 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 2000 | 108 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2000 | 124 | 0.010 |
Why?
|
| Carcinoma | 2 | 1971 | 2385 | 0.010 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 1980 | 86 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2005 | 673 | 0.010 |
Why?
|
| 18-Hydroxycorticosterone | 1 | 1979 | 3 | 0.010 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 1979 | 13 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1981 | 270 | 0.010 |
Why?
|
| Leptin | 1 | 2008 | 1621 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 2 | 1998 | 1272 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2846 | 0.010 |
Why?
|
| Action Potentials | 1 | 1987 | 1807 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1987 | 1521 | 0.010 |
Why?
|
| Darkness | 1 | 1999 | 160 | 0.010 |
Why?
|
| Glucagon | 2 | 1972 | 535 | 0.010 |
Why?
|
| Binding Sites | 1 | 1988 | 6118 | 0.010 |
Why?
|
| Cadmium | 1 | 2000 | 211 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2003 | 979 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1981 | 368 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7355 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 1447 | 0.010 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2001 | 259 | 0.010 |
Why?
|
| Cell Size | 1 | 2000 | 639 | 0.010 |
Why?
|
| Propanolamines | 1 | 1979 | 164 | 0.010 |
Why?
|
| Serotonin | 1 | 1983 | 1034 | 0.010 |
Why?
|
| Prekallikrein | 1 | 1977 | 11 | 0.010 |
Why?
|
| Cell Count | 1 | 1982 | 1856 | 0.010 |
Why?
|
| Delusions | 1 | 2000 | 300 | 0.010 |
Why?
|
| Women's Health | 1 | 2008 | 2059 | 0.010 |
Why?
|
| Renal Artery Obstruction | 1 | 1979 | 246 | 0.010 |
Why?
|
| Hypothalamic Hormones | 1 | 1999 | 147 | 0.010 |
Why?
|
| Osmosis | 1 | 1997 | 112 | 0.010 |
Why?
|
| Hallucinations | 1 | 2000 | 361 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 2 | 1977 | 272 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1981 | 653 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 2090 | 0.010 |
Why?
|
| Papaverine | 1 | 1997 | 46 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1999 | 879 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2888 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 2514 | 0.010 |
Why?
|
| Alprostadil | 1 | 1997 | 89 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9863 | 0.010 |
Why?
|
| Dysgerminoma | 2 | 1974 | 67 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1987 | 2072 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 1675 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 2622 | 0.010 |
Why?
|
| Homosexuality | 2 | 1975 | 262 | 0.010 |
Why?
|
| Pregnanetriol | 2 | 1977 | 4 | 0.010 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2000 | 478 | 0.010 |
Why?
|
| Fetal Blood | 2 | 1994 | 1332 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2376 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1979 | 965 | 0.010 |
Why?
|
| Dihydrotestosterone | 2 | 1975 | 193 | 0.010 |
Why?
|
| Necrosis | 1 | 2000 | 1641 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 1981 | 644 | 0.010 |
Why?
|
| Overweight | 1 | 2007 | 2393 | 0.010 |
Why?
|
| Body Temperature | 1 | 1999 | 770 | 0.010 |
Why?
|
| Image Enhancement | 1 | 1987 | 2913 | 0.010 |
Why?
|
| Adenofibroma | 1 | 1975 | 25 | 0.010 |
Why?
|
| Microcirculation | 1 | 2000 | 1307 | 0.010 |
Why?
|
| Mastitis | 1 | 1975 | 41 | 0.010 |
Why?
|
| Calcimycin | 1 | 1995 | 222 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 35447 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1995 | 284 | 0.010 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1994 | 93 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 1975 | 113 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 6093 | 0.010 |
Why?
|
| Liver Diseases | 2 | 1994 | 1264 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 397 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 1993 | 404 | 0.010 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 1976 | 190 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 41390 | 0.010 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 1974 | 31 | 0.010 |
Why?
|
| Altitude | 1 | 1975 | 160 | 0.010 |
Why?
|
| Virilism | 1 | 1974 | 31 | 0.010 |
Why?
|
| Leukocytes | 1 | 1982 | 2056 | 0.010 |
Why?
|
| Hypophysectomy | 2 | 1971 | 113 | 0.010 |
Why?
|
| Injections | 1 | 1997 | 842 | 0.010 |
Why?
|
| Ketosteroids | 1 | 1973 | 3 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1973 | 91 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1984 | 5552 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 1976 | 566 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1972 | 74 | 0.010 |
Why?
|
| Plasma Volume | 1 | 1972 | 36 | 0.010 |
Why?
|
| Premenopause | 1 | 1997 | 1034 | 0.010 |
Why?
|
| Blood | 1 | 1975 | 593 | 0.010 |
Why?
|
| Hypotension | 1 | 1979 | 888 | 0.010 |
Why?
|
| Mandelic Acids | 1 | 1972 | 46 | 0.010 |
Why?
|
| Clomiphene | 1 | 1972 | 71 | 0.010 |
Why?
|
| Ion Exchange | 1 | 1992 | 16 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1975 | 694 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1972 | 6699 | 0.010 |
Why?
|
| Arousal | 1 | 1998 | 1164 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3131 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2005 | 3487 | 0.010 |
Why?
|
| Bufanolides | 1 | 1991 | 5 | 0.010 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1991 | 40 | 0.010 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1992 | 104 | 0.010 |
Why?
|
| Genome, Human | 1 | 2005 | 4446 | 0.010 |
Why?
|
| Echocardiography | 1 | 2004 | 5117 | 0.010 |
Why?
|
| Anions | 1 | 1992 | 135 | 0.010 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1975 | 248 | 0.010 |
Why?
|
| Inulin | 1 | 1991 | 84 | 0.010 |
Why?
|
| Acids | 1 | 1992 | 126 | 0.010 |
Why?
|
| Amenorrhea | 2 | 1974 | 502 | 0.010 |
Why?
|
| Carbon Dioxide | 2 | 1992 | 1162 | 0.010 |
Why?
|
| Research Design | 1 | 1987 | 6118 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1976 | 1232 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1978 | 1356 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 1992 | 163 | 0.010 |
Why?
|
| Sodium Radioisotopes | 1 | 1990 | 6 | 0.010 |
Why?
|
| Drug Contamination | 1 | 1972 | 148 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1991 | 260 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1992 | 312 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 1973 | 296 | 0.010 |
Why?
|
| Vasopressins | 1 | 1972 | 369 | 0.010 |
Why?
|
| Teriparatide | 1 | 1992 | 225 | 0.010 |
Why?
|
| Culture Media | 1 | 1972 | 908 | 0.010 |
Why?
|
| Bloodletting | 1 | 1970 | 23 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1990 | 235 | 0.010 |
Why?
|
| Nephrectomy | 2 | 1973 | 1046 | 0.010 |
Why?
|
| Bronchitis | 1 | 1971 | 199 | 0.010 |
Why?
|
| Photometry | 1 | 1970 | 58 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 10252 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1975 | 2730 | 0.010 |
Why?
|
| Coronary Thrombosis | 1 | 1993 | 495 | 0.010 |
Why?
|
| Immunoelectrophoresis | 1 | 1969 | 110 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1969 | 163 | 0.010 |
Why?
|
| Sex Chromatin | 1 | 1969 | 20 | 0.010 |
Why?
|
| Basal Metabolism | 1 | 1970 | 167 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 1972 | 409 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2000 | 2738 | 0.010 |
Why?
|
| Cytophotometry | 1 | 1988 | 7 | 0.010 |
Why?
|
| Prednisone | 2 | 1971 | 1585 | 0.010 |
Why?
|
| Emotions | 1 | 1981 | 2684 | 0.010 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1969 | 125 | 0.010 |
Why?
|
| Aspirin | 1 | 1981 | 3332 | 0.010 |
Why?
|
| Hypoglycemia | 2 | 1972 | 862 | 0.000 |
Why?
|
| Fetus | 1 | 1975 | 1889 | 0.000 |
Why?
|
| Injections, Intravenous | 3 | 1980 | 1420 | 0.000 |
Why?
|
| Congenital Abnormalities | 1 | 1972 | 712 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1984 | 9300 | 0.000 |
Why?
|
| Jejunum | 1 | 1969 | 478 | 0.000 |
Why?
|
| Androgens | 1 | 1974 | 1289 | 0.000 |
Why?
|
| Anesthesia, Local | 1 | 1969 | 275 | 0.000 |
Why?
|
| Clinical Protocols | 1 | 1993 | 1463 | 0.000 |
Why?
|
| Testicular Neoplasms | 1 | 1973 | 814 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1969 | 512 | 0.000 |
Why?
|
| Adenocarcinoma | 2 | 1975 | 6387 | 0.000 |
Why?
|
| Chorionic Gonadotropin | 1 | 1968 | 479 | 0.000 |
Why?
|
| Hippurates | 1 | 1985 | 16 | 0.000 |
Why?
|
| Smoking | 1 | 2003 | 9030 | 0.000 |
Why?
|
| Succinimides | 1 | 1985 | 79 | 0.000 |
Why?
|
| Anesthesia | 1 | 1997 | 1577 | 0.000 |
Why?
|
| Phospholipids | 1 | 1969 | 785 | 0.000 |
Why?
|
| Time | 1 | 1987 | 548 | 0.000 |
Why?
|
| Sarcoidosis | 1 | 1971 | 514 | 0.000 |
Why?
|
| Data Collection | 1 | 1994 | 3350 | 0.000 |
Why?
|
| Androstenedione | 2 | 1975 | 131 | 0.000 |
Why?
|
| Postpartum Period | 1 | 1992 | 1143 | 0.000 |
Why?
|
| Trypsin | 1 | 1985 | 509 | 0.000 |
Why?
|
| Vitamin E | 1 | 1969 | 876 | 0.000 |
Why?
|
| Lithium | 1 | 1988 | 605 | 0.000 |
Why?
|
| Liver Circulation | 1 | 1984 | 164 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1985 | 547 | 0.000 |
Why?
|
| Feces | 1 | 1970 | 1419 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1973 | 1749 | 0.000 |
Why?
|
| Lipoproteins | 1 | 1969 | 885 | 0.000 |
Why?
|
| Carbon Radioisotopes | 2 | 1975 | 577 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1969 | 1806 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1985 | 1035 | 0.000 |
Why?
|
| Phenoxybenzamine | 1 | 1981 | 54 | 0.000 |
Why?
|
| Hydralazine | 1 | 1981 | 37 | 0.000 |
Why?
|
| Phentolamine | 1 | 1981 | 104 | 0.000 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1981 | 149 | 0.000 |
Why?
|
| Parasympatholytics | 1 | 1981 | 91 | 0.000 |
Why?
|
| Constriction | 1 | 1981 | 180 | 0.000 |
Why?
|
| Fatty Acids | 1 | 1969 | 1788 | 0.000 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1981 | 174 | 0.000 |
Why?
|
| Prostaglandins F | 1 | 1980 | 81 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1971 | 4881 | 0.000 |
Why?
|
| Breast Neoplasms | 2 | 1979 | 20914 | 0.000 |
Why?
|
| Intraoperative Period | 1 | 1981 | 517 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1992 | 5124 | 0.000 |
Why?
|
| Nitrates | 1 | 1981 | 268 | 0.000 |
Why?
|
| Feminization | 2 | 1969 | 23 | 0.000 |
Why?
|
| Aorta, Abdominal | 1 | 1981 | 641 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1969 | 3062 | 0.000 |
Why?
|
| Sebum | 1 | 1977 | 16 | 0.000 |
Why?
|
| Postoperative Period | 1 | 1981 | 1848 | 0.000 |
Why?
|
| Melanosis | 1 | 1976 | 85 | 0.000 |
Why?
|
| Depression | 2 | 1972 | 7876 | 0.000 |
Why?
|
| Aprotinin | 1 | 1975 | 88 | 0.000 |
Why?
|
| Ketosis | 1 | 1975 | 46 | 0.000 |
Why?
|
| Leydig Cells | 1 | 1974 | 57 | 0.000 |
Why?
|
| Acclimatization | 1 | 1975 | 105 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1975 | 719 | 0.000 |
Why?
|
| Chronic Disease | 2 | 1981 | 9223 | 0.000 |
Why?
|
| Clitoris | 1 | 1974 | 34 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1975 | 1395 | 0.000 |
Why?
|
| Progestins | 1 | 1976 | 309 | 0.000 |
Why?
|
| Tolbutamide | 1 | 1972 | 23 | 0.000 |
Why?
|
| Water Intoxication | 1 | 1972 | 10 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1972 | 25903 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1972 | 307 | 0.000 |
Why?
|
| Diabetes Insipidus | 1 | 1972 | 150 | 0.000 |
Why?
|
| Pituitary Irradiation | 1 | 1970 | 17 | 0.000 |
Why?
|
| Radiation Effects | 1 | 1970 | 68 | 0.000 |
Why?
|
| Puberty | 1 | 1974 | 492 | 0.000 |
Why?
|
| Estriol | 1 | 1969 | 53 | 0.000 |
Why?
|
| Chromatography | 1 | 1969 | 205 | 0.000 |
Why?
|
| Cervix Uteri | 1 | 1974 | 591 | 0.000 |
Why?
|
| Uterus | 1 | 1974 | 695 | 0.000 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 1 | 1969 | 41 | 0.000 |
Why?
|
| Ovary | 1 | 1974 | 983 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1975 | 1537 | 0.000 |
Why?
|
| Psychophysiology | 1 | 1969 | 135 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1970 | 680 | 0.000 |
Why?
|
| Dehydroepiandrosterone | 1 | 1969 | 254 | 0.000 |
Why?
|
| Phenytoin | 1 | 1969 | 199 | 0.000 |
Why?
|
| Pregnancy Tests | 1 | 1968 | 30 | 0.000 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1968 | 72 | 0.000 |
Why?
|
| Respiration | 1 | 1975 | 1674 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1981 | 5103 | 0.000 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1969 | 288 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1969 | 744 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1968 | 558 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1969 | 868 | 0.000 |
Why?
|
| Length of Stay | 1 | 1980 | 6355 | 0.000 |
Why?
|
| Gestational Age | 1 | 1975 | 3555 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1981 | 4185 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1970 | 1066 | 0.000 |
Why?
|
| Psychotherapy | 1 | 1973 | 1657 | 0.000 |
Why?
|
| Oxygen | 1 | 1975 | 4208 | 0.000 |
Why?
|
| Swine | 1 | 1972 | 5965 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1981 | 15459 | 0.000 |
Why?
|